logo BDSP

Base documentaire


Votre avis nous intéresse

Le réseau BDSP met en oeuvre un projet d'innovation et d'amélioration de ses services, dans le souci constant de proposer des contenus de qualité adaptés aux besoins des utilisateurs.

Identifier de nouvelles sources de financements est la condition nécessaire pour assurer la poursuite et la pérennité de cet outil unique qu'est la BDSP, tout en le faisant évoluer.

Pour définir un nouveau modèle économique, nous avons besoin de votre avis : merci de répondre à notre enquête (temps estimé : 5 minutes).

Participer maintenant
Participer plus tard J'ai déjà participé

  1. Depot medroxyprogesterone acetate (Depo-Provera) and levonorgestrel (Norplant) use in adolescents among clinicians in Northern Europe and the United States.

    Article - En anglais

    Purpose 

    To compare attitudes and practices related to clinicians'use of depot medroxyprogesterone acetate [Depo-Provera (DMPA) ] and levonorgestrel implants in adolescents in three northern European countries and the United States.

    Methods 

    Between the fall of 1993 and the winter of 1995, surveys eliciting clinician attitudes and practices with the two contraceptive methods were collected from practitioners who provide contraceptive care to teens in Sweden (n=282), The Netherlands (n=197), Great Britain (n=108), and the United States (n=548).

    Results 

    Clinicians in Great Britain and the United States reported prescribing of DMPA, selected DMPA in their top three choices for contraception in teens, and had patients ask about DMPA more frequently than clinicians in Sweden or The Netherlands (p<0.0001).

    U.S. clinicians were more likely to report prescribing of the implants, list them as a top choice, and have patients ask for it more frequently than were providers in the other three countries (p<0.0001).

    Noncompliance with previous contraceptives was the most common indication for use of either method in this age group. « Worst fears » with DMPA use included infertility, particularly among Swedish clinicians (p<0.0001), as was pregnancy and loss to follow-up, particularly among British clinicians (p<0.0001).

    Condom nonuse was a concern associated with both methods. (...)

    Mots-clés Pascal : Prévention, Gestation, Contraception, Lévonorgestrel, Médroxyprogestérone, Contraceptif, Personnel sanitaire, Attitude, Etude comparative, Etats Unis, Amérique du Nord, Amérique, Europe, Forme libération contrôlée, Adolescent, Homme, Femelle

    Mots-clés Pascal anglais : Prevention, Pregnancy, Contraception, Levonorgestrel, Medroxyprogesterone, Contraceptive, Health staff, Attitude, Comparative study, United States, North America, America, Europe, Controlled release form, Adolescent, Human, Female

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 98-0448527

    Code Inist : 002B20A01. Création : 25/01/1999.